Pricing Log in Create free account

Pliant Therapeutics, Inc. (PLRX) vs Rein Therapeutics Inc. (RNTX)

Pliant Therapeutics, Inc. and Rein Therapeutics Inc. are both Biotechnology companies. Pliant Therapeutics, Inc. and Rein Therapeutics Inc. are of similar size ($52.8M and $50.5M). Across the 8 metrics below, Pliant Therapeutics, Inc. leads on 5 and Rein Therapeutics Inc. on 3.

Valuation

Metric PLRX RNTX Biotechnology median
P/E n/m n/m 10.60
P/S 9.98 n/m 9.40
P/B 0.34 4.01 2.13
Price to free cash flow n/m n/m 25.18
EV/EBITDA 0.81 n/m 0.66
EV/Sales (15.42) n/m 9.02
Earnings yield (183.95%) (281.97%) (32.88%)
Free cash flow yield (140.81%) (45.77%) (23.13%)

Profitability

Metric PLRX RNTX Biotechnology median
Gross margin 0.00% 0.00% 68.51%
Operating margin 0.00% 0.00% 0.00%
Net margin 0.00% 0.00% 0.00%
Free cash flow margin 0.00% 0.00% 0.00%
Return on equity (50.29%) (753.55%) (51.96%)
Return on assets (37.69%) (80.62%) (46.06%)
Return on invested capital 0.00% 0.00% 0.00%

Growth

Metric PLRX RNTX Biotechnology median
Revenue growth (TTM) (48.95%) — 6.76%
EPS growth (last fiscal year) 29.97% 44.16% 29.88%
Revenue growth, 5-year CAGR — — 9.75%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric PLRX RNTX Biotechnology median
Debt to equity 0.00 0.00 0.00
Current ratio 9.90 4.27 4.97
Net debt to EBITDA 1.27 0.15 1.01

Dividend

Metric PLRX RNTX Biotechnology median
Dividend yield — — 0.41%
Payout ratio — — —

Size

Metric PLRX RNTX Biotechnology median
Market cap 50.52m 52.79m 161.82m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack